metricas
covid
Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Inhaled therapy in asthma
Journal Information
Vol. 146. Issue 7.
Pages 316-323 (April 2016)
Share
Share
Download PDF
More article options
Visits
1
Vol. 146. Issue 7.
Pages 316-323 (April 2016)
Review
Inhaled therapy in asthma
Terapia inhalada en el asma
Visits
1
Vicente Plaza Moral
Corresponding author
vplaza@santpau.cat

Corresponding author.
, Jordi Giner Donaire
Servicio de Neumología, Hospital de la Santa Creu i Sant Pau, Institut d’Investigació Biomédica Sant Pau (IIB Sant Pau), Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Tables (4)
Table 1. Deposits and mass median aerodynamic diameter of aerosols provided by inhalers.
Table 2. Equipotent doses of inhaled glucocorticoids in alphabetical order.
Table 3. Inhaled medications for the treatment of asthma or chronic obstructive pulmonary disease commercialised in Spain in 2015.
Table 4. Recommended steps for patient education-instruction in the correct inhalation technique for the device, at the initial visit and the follow-up steps.
Show moreShow less
Abstract

Because of its advantages, inhaled administration of aerosolised drugs is the administration route of choice for the treatment of asthma and COPD. Numerous technological advances in the devices used in inhaled therapy in recent decades have boosted the appearance of multiple inhalers and aerosolised drugs. However, this variety also requires that the prescribing physician is aware of their characteristics. The main objective of the present review is to summarise the current state of knowledge on inhalers and inhaled drugs commonly used in the treatment of asthma. The review ranges from theoretical aspects (fundamentals and available devices and drugs) to practical and relevant aspects for asthma care in the clinical setting (therapeutic strategies, education, and adherence to inhalers).

Keywords:
Asthma
Aerosolised drugs
Resumen

La administración de fármacos aerosolizados mediante la vía inhalada, dadas sus ventajas, constituye la vía de administración de elección para el tratamiento del asma y de la EPOC. El desarrollo tecnológico experimentado en las últimas décadas ha propiciado la aparición de múltiples inhaladores y fármacos aerosolizables. Tal variedad obliga al facultativo que los debe prescribir a conocerlos en profundidad. La presente revisión tiene como principal objetivo resumir el estado actual del conocimiento sobre inhaladores y fármacos inhalados habitualmente empleados en el tratamiento de mantenimiento y de la exacerbación del asma. El texto aborda desde aspectos teóricos (fundamentos, dispositivos y fármacos disponibles), a otros más prácticos y de relevancia en la asistencia clínica diaria del asma (pautas terapéuticas, educación y adhesión a los inhaladores).

Palabras clave:
Asma
Fármacos aerosolizados

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.medcle.2021.04.034
No mostrar más